Articles of the Month
Videos
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Articles
Outcomes of Covid19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders
Giannetti, M.P., Olivieri, F., Godwin, G., et al. Allergy. First published: 13 August 2022
Predicting probability of tolerating discrete amounts of peanut protein in allergic children using epitope-specific IgE antibody profiling
Suprun, M., Kearney, P., Hayward, C., et al. Allergy. First published: 12 August 2022
Alarming inflammation: the TGFβ1–Nrp1 pathway upregulates the IL-33 axis in lung ILC2s
Salvati, L. and Mazzoni, A. Allergy. First published: 12 August 2022
Association between EBV reactivation and development of Long-COVID fatigue
Rohrhofer, J., Graninger, M., Lettenmaier, L., et al. Allergy. First published: 11 August 2022
Biologics and airway aemodeling in severe asthma
Varricchi, G., Ferri, S., Pepys, J., et al. Allergy. First published: 11 August 2022
Reliability of the electro-medical device Nexkin DSPT® for wheal size measurement in allergy skin testing: An exploratory clinical trial
Morales-Palacios, M.P., Núñez-Córdoba, J.M., Tejero, E., et al. Allergy. First published: 11 August 2022
Murine lung cDC1s inhibit memory Th2 cell generation by reducing CD62L+ memory precursors via IL-12
Liu, J., Du, L., Yi, S., et al. Allergy. First published: 07 August 2022
Correspondence to “Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus”
Smith, P.K., Lesslar, O. and Price, D.B. et al. Allergy. First published: 06 August 2022
Reply to correspondence to ‘Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus’
Hagemann, J., Zuberbier, T., Walter Canonica, G., et al. Allergy. First published: 06 August 2022
Corrigendum for “Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns”
Shi, L.-L. and Liu, Z. Allergy. First published: 06 August 2022
Safety of COVID-19 vaccine challenge in patients with immediate adverse reactions to prior doses: A multi-centre cohort study
De Luca, J.F., Awad, A., Vogrin, S., et al. First published: 04 August 2022
The impact of maternal-fetal omalizumab transfer on peanut-specific responses in an ex vivo placental perfusion model
Kothari, A., Hirschmugl, B., Lee, J.-S., et al. First published: 04 August 2022
Impact of air pollution and meteorological factors on incidence of allergic rhinitis: A low-latitude multi-city study in China
Luo, X., Hong, H., Lu, Y., et al. First published: 04 August 2022
Different aspects of severe asthma in real life: role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity
Caruso, C., Colantuono, S., Ciasca, G., et al. Allergy. First published: 03 August 2022
The abundance of Ruminococcus bromii is associated with faecal butyrate levels and atopic dermatitis in infancy
Sasaki, M., Schwab, C., Ramirez Garcia, A., et al. Allergy. First published: 02 August 2022
Biostatistics in Allergy - recommendations for authors
Ordak, M. Allergy. First published: 02 August 2022
Fel d 1 surface expression on plant-made eBioparticles combines potent immune activation and hypo-allergenicity
Busold, S., Aglas, L., Menage, C., et al. Allergy. First published: 02 August 2022
CEACAM5 is an IL-13-regulated epithelial gene that mediates transcription in type-2 (T2) high severe asthma
Mumby, S., Kermani, N.Z., Garnett, J.P., et al. Allergy. First published: 02 August 2022
Human neutrophils require short exposure to cytokines and allergen to become functional antigen-presenting cells
Polak, D., Elbe-Bürger, A., Kitzmüller, C., Zlabinger, G.J. and Bohle, B. Allergy. First published: 01 August 2022
Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines
Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022
Citations: 1574
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 470
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Citations: 274
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Citations: 249
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Citations: 241
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Citations: 175
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Citations: 115
Type 2 immunity in the skin and lungs
Akdis, CA, Arkwright, PD, Brüggen, MC, et al. Allergy. 2020; 75: 1582– 1605
Citations: 87
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Citations: 69
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444
Citations: 69
Towards a more precise diagnosis of hypersensitivity to beta-lactams — an EAACI position paper
Romano, A, Atanaskovic-Markovic, M, Barbaud, A, et al. Allergy. 2020; 75: 1300– 1315
Citations: 69
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines
Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022
SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation
Jeong, J.S., Choi, J.Y., Kim, J.S., et al. Allergy. First published: 24 July 2022
Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies
Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022
Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry
Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022
The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma
Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022
Presentation of airway and general symptoms in COVID-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus
et al. Allergy. First published: 14 June 2022
Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection
Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post–infection and post-vaccination cellular SARS-CoV-2-specific immune response
Kratzer, B., Schlax, L.C., Gattinger, P., et al. Allergy. First published: 12 June 2022
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab
Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
Are health care policies for COVID-19 evidence-based?
Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022
Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro
Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022
Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?
Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
August 2022 - COVID vaccines and new variants: the light at the end of the tunnel
Volume 77 | Issue 8
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Junior Members Corner
Dear Junior Members,
EAACI Hybrid Congress 2022
The EAACI annual congress 2022 was held on 1-3 July with a hybrid format. Online and in person in Prague, Czech Republic. The event was a solid success! Onsite attendance reached 4,500 delegates, while 3,000 delegates tuned it from all 5 continents - over 100 countries represented in a diverse and extremely rich audience. The congress delivered more than 80 scientific sessions as part of an extensive program tailored to offer the most advanced research available in our specialty.
The meeting represented a wonderful opportunity for the EAACI Junior Members (JM) to improve their knowledge and expand their collaborative network. During the congress, the JMA organized several activities dedicated to the juniors:
On Friday, 01 July 2022, in the JM Scientific Symposium “Exploring the AXIS communications in allergy and chronic diseases” the speakers, Riccardo Castagnoli, Elisabeth Tham and Giada De Palma presented the complex interplays that characterize the immune-gut, the skin-gut and the brain-gut axis.
On Saturday, 02 July 2022, during the Educational Session, Cezmi Akdis, Thomas Eiwegger, and Anna Globinska instructed the audience with helpful advice to improve paper writing skills, better deal with peer-review process and graphically represent the results. Moreover, several JM were able to present their data at the JM Case report session and JM Poster session.
The congress also represented the opportunity to meet the students who attended the EAACI Allergy College. EAACI is doing a tremendous effort to promote education on Allergology among students and fellows around the world. The Allergy College program gives to undergraduate students the possibility to collaborate with mentors, selected for their prominent expertise. These collaborations were extremely fruitful with many students actively involved in the congress.
In addition, during the congress, the EAACI Knowledge Hub was launched. It represents a fresh and interactive digital platform where scientific and educational resources are made available to the EAACI members. In the EAACI Knowledge Hub it is possible to read the latest research in terms of guidelines, books, journals, position papers and much more… we encourage you to explore it!
Moreover, on Saturday, 02 July 2022, the new Molecular Allergology User’s Guide 2.0 was presented. After the success of the first edition of “EAACI Molecular Allergology User’s Guide”, the new Molecular Allergology User’s Guide 2.0 provides state-of-the-art information on allergen molecules, their clinical relevance and application in diagnostic algorithms for clinical practice. You can find more about Molecular Allergology User’s Guide 2 by clicking here
Finally, the initiative “Beat Allergy Run & Walk in Prague!” represented a way to to raise awareness about allergy and a great opportunity for JM to meet each other running.
The 2022 annual congress has been a wonderful experience! It might be over, but we are already looking forward to meeting again in Hamburg, Germany and online on June 9-11 at the EAACI Hybrid Congress 2023!
Best regards,
The Junior Member Assembly
